Stanley J. Schmidt - Concepedia

Concepedia

Author

Stanley J. Schmidt

Also Known As

S J Schmidt, S. J. SCHMIDT, SCHMIDT,Stanley J., STANLEY J. SCHMIDT, Stanley J Schmidt, Stanley J. Schmidt, Stanley Schmidt

41

Publications

1.5K

Citations

16

H-Index

54

Concepts

All Affiliations

South College GlaxoSmithKline (United States)New Frontier Institute of Molecular Biology and Biophysics

SJ

About

Stanley J. Schmidt is an author at South College specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.2K
2	Natural Sciences	11	11	627
3	Biochemistry	10	10	563
4	Engineering	2	2	114
5	Public Health	1	1	44

Stanley J. Schmidt

×

21

Publications

1.5K

Citations

16

H-Index

	Year	Citations
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess, ACS Medicinal Chemistry Letters Highly Potent InhibitorTumor BiologyMammalian TargetSignaling PathwayCancer Cell Biology	2010	367
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia Ujunwa Cynthia Okoye-Okafor, Boris Bartholdy, Jessy Cartier, Nature Chemical Biology Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaPharmacology	2015	174
P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme Roland E. Dolle, C. V. C. Prasad, Stanley J. Schmidt, Journal of Medicinal Chemistry Interleukin-1.beta.-converting EnzymeImmunologyAltmetric Attention ScorePeptide ScienceChemical Biology	1994	146
Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase Nicholas D. Adams, Jerry L. Adams, Joelle L. Burgess, Journal of Medicinal Chemistry Aurora B/c KinaseChemoprevention StrategyMolecular BiologyTumor BiologyMolecular Pharmacology	2010	108
Palladium catalysed alkoxycarbonylation of phenols to benzoate esters Roland E. Dolle, Stanley J. Schmidt, Lawrence I. Kruse Journal of the Chemical Society Chemical Communications Cross-coupling ReactionEngineeringSpectra-structure CorrelationOrganic ChemistryR. E. Dolle	1987	98
Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT) Hongfang Yang, Patrícia Flores de Medeiros, Kaushik Raha, ACS Medicinal Chemistry Letters Molecular DockingDrug TargetBiochemistryStructural BioinformaticsMedicine	2015	74
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295 Xiangping Qian, Andrew McDonald, Han-Jie Zhou, ACS Medicinal Chemistry Letters Molecular BiologyNew GenerationCancer BiologyPharmaceutical ChemistryMedicinal Chemistry	2010	64
Studies on the active site of succinyl-CoA:tetrahydrodipicolinate N-succinyltransferase. Characterization using analogs of tetrahydrodipicolinate. David A. Berges, Walter E. DeWolf, George L. Dunn, Journal of Biological Chemistry	1986	54
Nonpeptidic urotensin‐II receptor antagonists I: <i>in vitro</i> pharmacological characterization of SB‐706375 Stephen A. Douglas, David J. Behm, Nambi Aiyar, British Journal of Pharmacology Hu-ii BindingMolecular BiologyRat AortaPharmacotherapyExperimental Pharmacology	2005	53
Pyridazinodiazepines as a High-Affinity, P<sub>2</sub>−P<sub>3</sub>Peptidomimetic Class of Interleukin-1β-Converting Enzyme Inhibitor Roland E. Dolle, C. V. C. Prasad, Catherine Prouty, Journal of Medicinal Chemistry ImmunologyAltmetric Attention ScoreInterleukin-1β-converting Enzyme InhibitorPharmacotherapySystem Pharmacology	1997	52

Page 1